查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600157

微创青光眼手术设备市场：按设备、适应症、手术、最终用户划分 - 全球预测 2025-2030

Minimally Invasive Glaucoma Surgery Devices Market by Device (Micro-Stents, Suprachoroidal Devices, Trabecular Meshwork Devices), Indication (Closed-Angle Glaucoma, Open-Angle Glaucoma), Surgery, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年微创青光眼手术器械市值为5.0135亿美元，预计2024年将达到5.2662亿美元，复合年增长率为5.35%，2030年将达到7.2255亿美元。

微创青光眼手术 (MIGS) 设备旨在降低眼内压，主要用于轻度至中度青光眼患者。由于它比传统手术方法侵入性更小，因此已成为眼科手术中极其重要的发展。 MIGS 设备的范围涵盖了由于世界人口老化、青光眼盛行率不断上升以及对更安全的替代治疗的需求而产生的需求。这些装置可以以多种形式应用，包括支架和分流器，并且通常由眼科医生单独使用或与白内障手术结合使用。最终用途范围包括诊所、医院和门诊手术中心，但由于拥有熟练的专业人员和先进的设备，医院目前占据主导地位。

主要市场统计
基准年[2023] 50135万美元
预测年份 [2024] 5.2662亿美元
预测年份 [2030] 72255万美元
复合年增长率（%） 5.35%

MIGS 市场的主要成长动力包括与老龄化相关的眼部疾病发生率的上升以及对青光眼的认识的提高。此外，对门诊手术日益增长的偏好也支持了市场的扩张。有开发先进且具有成本效益的设备的机会，以提高发展中地区的可及性和采用率。鼓励公司投资专注于升级技术和探索新手术技术的研究和合作关係。然而，该市场受到 MIGS 设备成本高、术后併发症的可能性以及训练有素的专业人员数量有限的限制。

某些地区严格的监管要求和缺乏报销政策等挑战也可能阻碍市场成长。为了促进创新，公司应专注于开发下一代生物相容性材料并提高设备可用性，这可以进一步扩大应用范围。探索针对患者的治疗方案和个人化照护模式是业务成长的宝贵前沿。 MIGS市场的特点是竞争温和，主要参与者专注于研发以保持竞争优势。

市场动态：快速发展的微创青光眼手术器材市场的关键市场洞察

供需的动态交互作用正在改变微创青光眼手术器械市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 对微创手术设备的偏好日益增长
    • 世界老年人口的增加
    • 提高对青光眼早期检测的认识促进了微创手术设备的采用
  • 市场限制因素
    • 微创青光眼手术设备成本高
  • 市场机会
    • 加大研发投入，创新有效的青光眼手术器械
    • 远端医疗和远端患者监护的进展
  • 市场挑战
    • 引进新的青光眼手术设备存在监管障碍和漫长的核准流程

波特五力：驾驭微创青光眼手术器械市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解微创青光眼手术器械市场的外部影响

外部宏观环境因素在塑造微创青光眼手术器械市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解微创青光眼手术器材市场竞争状况

对微创青光眼手术设备市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵微创青光眼手术器械市场供应商的绩效评估

FPNV 定位矩阵是评估微创青光眼手术设备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，以规划微创青光眼手术器材市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对微创青光眼手术器械市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对微创手术设备的偏好增加
      • 全球人口老化仍在持续
      • 人们对青光眼早期检测的认识不断提高，正在推动微创手术设备的引进
    • 抑制因素
      • 微创青光眼手术设备成本高
    • 机会
      • 加大研发投入，创新有效的青光眼手术器械
      • 远端医疗和远端患者监护的进展
    • 任务
      • 引进新的青光眼手术设备需要监管障碍和漫长的核准过程
  • 市场区隔分析
    • 设备：早期至中期青光眼患者对微支架的青睐度增加
    • 最终用户：医院对微创青光眼手术 (MIGS) 设备的需求增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章微创青光眼手术器械市场：依器械分类

  • 微型支架
  • 脉络膜上腔装置
  • 小梁装置
  • 粘膜吻合器

第七章微创青光眼手术器械市场（按适应症）

  • 隅角闭锁性青光眼
  • 开放性青光眼

第八章依手术分類的微创青光眼手术器械市场

  • 从外部
  • 内部

第九章微创青光眼手术器械市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 眼科诊所

第十章北美及南美微创青光眼手术器械市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太微创青光眼手术器械市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲微创青光眼手术器械市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 新世界医疗增强型 Kahook 双刀片获得 510(k) 批准，扩大青光眼治疗选择和市场覆盖范围
    • Cytosciences 的 OMNI 手术系统在治疗青光眼方面显示出良好的效果，我们预计会有更广泛的采用和市场成长。
    • iSTAR Medical SA青光眼治疗仪获得CE标誌，进军美国市场
  • 战略分析和建议

公司名单

  • Abbott Medical Optics, Inc.
  • Alcon Inc.
  • Allergan PLC
  • Bausch & Lomb Inc.
  • Carl-Zeiss AG
  • Corza Ophthalmology
  • Ellex Medical Lasers Ltd.
  • Glaukos Corporation
  • InnFocus Inc.
  • IOPtima
  • iSTAR Medical
  • Ivantis, Inc.
  • Lumenis Be Ltd.
  • Neomedix Corporation
  • New World Medical, Inc.
  • Optonol Ltd.
  • Santen Pharmaceutical Co., Ltd.
  • Sight Sciences, Inc.
  • Topcon Corporation
Product Code: MRR-036C5CF3A869

The Minimally Invasive Glaucoma Surgery Devices Market was valued at USD 501.35 million in 2023, expected to reach USD 526.62 million in 2024, and is projected to grow at a CAGR of 5.35%, to USD 722.55 million by 2030.

Minimally Invasive Glaucoma Surgery (MIGS) devices are designed to reduce intraocular pressure and are primarily used in patients with mild-to-moderate glaucoma. Their less invasive nature compared to traditional surgical methods makes them a pivotal development in ophthalmic surgery. The scope of MIGS devices encompasses their necessity due to the aging global population, the increasing prevalence of glaucoma, and the demand for safer alternative treatments. These devices are applicable in various forms, including stents and shunts, which are regularly used by ophthalmologists in both standalone procedures and in conjunction with cataract surgery. End-use scope includes clinics, hospitals, and ambulatory surgical centers, with hospitals currently dominating due to the availability of skilled professionals and advanced facilities.

KEY MARKET STATISTICS
Base Year [2023] USD 501.35 million
Estimated Year [2024] USD 526.62 million
Forecast Year [2030] USD 722.55 million
CAGR (%) 5.35%

The key growth drivers of the MIGS market include the rising incidence of age-related eye disorders and increasing awareness regarding glaucoma. Additionally, the growing preference for outpatient surgical procedures boosts market expansion. Opportunities lie in developing advanced, yet more cost-effective devices to increase accessibility and adoption in developing regions. Companies are recommended to invest in research and partnerships focused on technology upgrades and exploring new surgical techniques. However, the market faces limitations due to the high cost of MIGS devices, potential complications post-surgery, and a limited number of skilled professionals.

Challenges like stringent regulatory requirements and lack of reimbursement policies in certain regions could impede market growth. To foster innovation, businesses should focus on the development of next-generation biocompatible materials and enhancing device user-friendliness, which could further broaden their application range. Research into patient-specific treatment options and personalized care models represents a valuable frontier for business growth. The MIGS market is characterized by moderate competition, with key players focused on R&D to maintain competitive advantages and the entry of new companies bringing innovative solutions expected to invigorate the sector further.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Minimally Invasive Glaucoma Surgery Devices Market

The Minimally Invasive Glaucoma Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the preference for minimally invasive surgery devices
    • Rising geriatric population globally
    • Growing awareness about early glaucoma detection promoting the adoption of minimally invasive surgical devices
  • Market Restraints
    • High costs of minimally invasive glaucoma surgery devices
  • Market Opportunities
    • Increasing investment in research and development for innovative and effective glaucoma surgery devices
    • Advancements in telemedicine and remote patient monitoring
  • Market Challenges
    • Regulatory hurdles and long approval processes for introducing new glaucoma surgery devices

Porter's Five Forces: A Strategic Tool for Navigating the Minimally Invasive Glaucoma Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Minimally Invasive Glaucoma Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Minimally Invasive Glaucoma Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Minimally Invasive Glaucoma Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Minimally Invasive Glaucoma Surgery Devices Market

A detailed market share analysis in the Minimally Invasive Glaucoma Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Minimally Invasive Glaucoma Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Minimally Invasive Glaucoma Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Minimally Invasive Glaucoma Surgery Devices Market

A strategic analysis of the Minimally Invasive Glaucoma Surgery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Minimally Invasive Glaucoma Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Medical Optics, Inc., Alcon Inc., Allergan PLC, Bausch & Lomb Inc., Carl-Zeiss AG, Corza Ophthalmology, Ellex Medical Lasers Ltd., Glaukos Corporation, InnFocus Inc., IOPtima, iSTAR Medical, Ivantis, Inc., Lumenis Be Ltd., Neomedix Corporation, New World Medical, Inc., Optonol Ltd., Santen Pharmaceutical Co., Ltd., Sight Sciences, Inc., and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Minimally Invasive Glaucoma Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device, market is studied across Micro-Stents, Suprachoroidal Devices, Trabecular Meshwork Devices, and Viscocanalostomy Devices.
  • Based on Indication, market is studied across Closed-Angle Glaucoma and Open-Angle Glaucoma.
  • Based on Surgery, market is studied across Ab Externo and Ab Interno.
  • Based on End-User, market is studied across Ambulatory Surgical Center, Hospital, and Ophthalmology Clinic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the preference for minimally invasive surgery devices
      • 5.1.1.2. Rising geriatric population globally
      • 5.1.1.3. Growing awareness about early glaucoma detection promoting the adoption of minimally invasive surgical devices
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of minimally invasive glaucoma surgery devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in research and development for innovative and effective glaucoma surgery devices
      • 5.1.3.2. Advancements in telemedicine and remote patient monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and long approval processes for introducing new glaucoma surgery devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device : Increasing preference for micro-stents for patients in the early-to-moderate stages of glaucoma
    • 5.2.2. End-user : Growing demand for minimally invasive glaucoma surgery (MIGS) devices in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Minimally Invasive Glaucoma Surgery Devices Market, by Device

  • 6.1. Introduction
  • 6.2. Micro-Stents
  • 6.3. Suprachoroidal Devices
  • 6.4. Trabecular Meshwork Devices
  • 6.5. Viscocanalostomy Devices

7. Minimally Invasive Glaucoma Surgery Devices Market, by Indication

  • 7.1. Introduction
  • 7.2. Closed-Angle Glaucoma
  • 7.3. Open-Angle Glaucoma

8. Minimally Invasive Glaucoma Surgery Devices Market, by Surgery

  • 8.1. Introduction
  • 8.2. Ab Externo
  • 8.3. Ab Interno

9. Minimally Invasive Glaucoma Surgery Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Center
  • 9.3. Hospital
  • 9.4. Ophthalmology Clinic

10. Americas Minimally Invasive Glaucoma Surgery Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Minimally Invasive Glaucoma Surgery Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Minimally Invasive Glaucoma Surgery Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. New World Medical Secures 510(k) Clearance for Expanded Kahook Dual Blade, Enhancing Glaucoma Treatment Options and Market Reach
    • 13.3.2. OMNI Surgical System by Sight Sciences Shows Promising Results in Glaucoma Treatment, Anticipating Wider Adoption and Market Growth
    • 13.3.3. iSTAR Medical SA Achieves CE Mark for Glaucoma Device, Eyes Expansion into U.S. Market
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Medical Optics, Inc.
  • 2. Alcon Inc.
  • 3. Allergan PLC
  • 4. Bausch & Lomb Inc.
  • 5. Carl-Zeiss AG
  • 6. Corza Ophthalmology
  • 7. Ellex Medical Lasers Ltd.
  • 8. Glaukos Corporation
  • 9. InnFocus Inc.
  • 10. IOPtima
  • 11. iSTAR Medical
  • 12. Ivantis, Inc.
  • 13. Lumenis Be Ltd.
  • 14. Neomedix Corporation
  • 15. New World Medical, Inc.
  • 16. Optonol Ltd.
  • 17. Santen Pharmaceutical Co., Ltd.
  • 18. Sight Sciences, Inc.
  • 19. Topcon Corporation

LIST OF FIGURES

  • FIGURE 1. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICRO-STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MESHWORK DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY VISCOCANALOSTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CLOSED-ANGLE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPEN-ANGLE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB EXTERNO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB INTERNO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023